DIGNITY Study
A lady from the DIGNITY study had contacted me. Below is our e-mail exchange. If you are interested in participating in the study, please contact her directly (see end of e-mails for her contact info.)
Hi Jackie, Nice to hear from you! Thank you for getting back to me so quickly. Will you be having another MUGA in the near future? About the HER2 Support group, yes that would be wonderful if you can help 'spread the word' and create awareness about this new trial. Any efforts you can provide are greatly appreciated. In the meantime, I will try to reach out to the webmaster as you've suggested. Please let me know how I can be of any help to you. All the best, Jeannette ----- Original Message ----- |
Re: DIGNITY Study
Recurrent Chest Wall Cancer after Mastectomy - http://rs6.net/on.jsp?t=110266073391.../images1/s.gifNew Breast Cancer Clinical Trial http://origin.ih.constantcontact.com...=1102660733912 If you are experiencing breast cancer with recurrence to the chest wall (RCW) or know someone who is, you may be interested in this clinical trial, the DIGNITY Study. Researchers are conducting the trial to determine the effectiveness of a novel investigational drug used in combination with heat therapy for the treatment of recurrent chest wall cancer (RCW). To participate in this trial, patients will: - Have a documented recurrence of breast cancer on the chest wall (or its overlying skin) - And have had: a mastectomy, radiation, and chemotherapy CLICK HERE TO FIND OUT IF YOU ARE ELIBIBLE TO PARTICIPATE: http://www.surveymonkey.com/s.aspx?sm=ZwRugqNJUfmD4lBtU0bsYQ_3d_3d SIGN UP HERE TO RECEIVE EMAIL UPDATES ABOUT THIS TRIAL: http://survey.constantcontact.com/survey/a07e2jzbhkofxyrqwh8/start Email updates will include: · A description of the investigational therapy and study requirements, · Eligibility criteria, · US trial site locations, · An opportunity to:
Jeannette Tighe at MedAdvisory Phone: 508-297-2439 Email: jtighe@medadvisory.net Kind regards, Jeannette Tighe Principal, MedAdvisory LLC www.medadvisory.net jtighe@medadvisory.net 508-297-2439 http://origin.ih.constantcontact.com...=1102660733912 Forward email http://img.constantcontact.com/lette...cribe_logo.gif This email was sent to mtime@sbcglobal.net by jtighe@medadvisory.net. Update Profile/Email Address | Instant removal with SafeUnsubscribe™ | Privacy Policy. Email Marketing by http://img.constantcontact.com/lette...o-color-sm.gif MedAdvisory LLC | 7 Glenn Road | North Easton | MA | 02356 |
Re: DIGNITY Study
If you are experiencing breast cancer with recurrence to the chest wall (RCW) or know someone who is, you may be interested in this clinical trial, the DIGNITY Study. Researchers are conducting the trial to determine the effectiveness of a novel investigational drug used in combination with heat therapy for the treatment of recurrent chest wall cancer (RCW).
To participate in this trial, patients will: - Have a documented recurrence of breast cancer on the chest wall (or its overlying skin) - And have had: a mastectomy, radiation, and chemotherapy CLICK HERE TO FIND OUT IF YOU ARE ELIGIBLE TO PARTICIPATE: http://www.surveymonkey.com/s.aspx?sm=ZwRugqNJUfmD4lBtU0bsYQ_3d_3d SIGN UP HERE TO RECEIVE EMAIL UPDATES ABOUT THIS TRIAL: http://survey.constantcontact.com/survey/a07e2jzbhkofxyrqwh8/start Email updates will include: · A description of the investigational therapy and study requirements, · Eligibility criteria, · US trial site locations, · An opportunity to:
Jeannette Tighe at MedAdvisory Phone: 508-297-2439 Email: jtighe@medadvisory.net Kind regards, Jeannette Tighe Principal, MedAdvisory LLC www.medadvisory.net jtighe@medadvisory.net 508-297-2439 |
All times are GMT -7. The time now is 07:15 AM. |
Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021